# 400:  Seaport's IPO adventure, obesity pill battles, and Makary's troubles

Page: https://stenobird.com/podcast/the-readout-loud-1134305/400-seaport-s-ipo-adventure-obesity-pill-battles-and-makary-s-troubles
Text version: https://stenobird.com/podcast/the-readout-loud-1134305/400-seaport-s-ipo-adventure-obesity-pill-battles-and-makary-s-troubles.md
Podcast: [The Readout Loud](https://stenobird.com/podcast/the-readout-loud-1134305)
Published: 2026-05-07T18:12:00+00:00
Episode link: https://traffic.megaphone.fm/TTSAA3808177194.mp3?updated=1778178131
Audio file: https://traffic.megaphone.fm/TTSAA3808177194.mp3?updated=1778178131
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/400-seaport-s-ipo-adventure-obesity-pill-battles-and-makary-s-troubles
Duration seconds: 1989

## Resource

On this week’s episode of "The Readout LOUD," we chat with Seaport Therapeutics CEO Daphne Zohar, fresh off the biotech’s successful IPO. Plus, Elaine, Allison, and Adam chat about this week’s notable news, including the obesity pill battle between Eli Lilly and Novo Nordisk, a Phase 3 study win for Cytokinetics, and FDA Commissioner Marty Makary’s White House troubles. Oh, by the way, this is the 400th episode of your favorite biotech podcast.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/400-seaport-s-ipo-adventure-obesity-pill-battles-and-makary-s-troubles/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-readout-loud-1134305/400-seaport-s-ipo-adventure-obesity-pill-battles-and-makary-s-troubles.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.